LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS
Robinson P, Maksymowych WP, Gensler LS, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, Deodhar A (2022)
In: Annals of the Rheumatic Diseases., 81(Suppl. 1). London: Bmj Publishing Group: 774-775.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Robinson, P.;
Maksymowych, W. P.;
Gensler, L. S.;
Rudwaleit, MartinUniBi;
Hoepken, B.;
Bauer, L.;
Kumke, T.;
Kim, M.;
Deodhar, A.
Einrichtung
Erscheinungsjahr
2022
Titel des Konferenzbandes
Annals of the Rheumatic Diseases
Band
81
Ausgabe
Suppl. 1
Seite(n)
774-775
ISSN
0003-4967
eISSN
1468-2060
Page URI
https://pub.uni-bielefeld.de/record/2966746
Zitieren
Robinson P, Maksymowych WP, Gensler LS, et al. LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS. In: Annals of the Rheumatic Diseases. Vol 81. London: Bmj Publishing Group; 2022: 774-775.
Robinson, P., Maksymowych, W. P., Gensler, L. S., Rudwaleit, M., Hoepken, B., Bauer, L., Kumke, T., et al. (2022). LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS. Annals of the Rheumatic Diseases, 81, 774-775. London: Bmj Publishing Group. https://doi.org/10.1136/annrheumdis-2022-eular.2834
Robinson, P., Maksymowych, W. P., Gensler, L. S., Rudwaleit, Martin, Hoepken, B., Bauer, L., Kumke, T., Kim, M., and Deodhar, A. 2022. “LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS”. In Annals of the Rheumatic Diseases, 81:774-775. London: Bmj Publishing Group.
Robinson, P., Maksymowych, W. P., Gensler, L. S., Rudwaleit, M., Hoepken, B., Bauer, L., Kumke, T., Kim, M., and Deodhar, A. (2022). “LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS” in Annals of the Rheumatic Diseases, vol. 81, (London: Bmj Publishing Group), 774-775.
Robinson, P., et al., 2022. LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS. In Annals of the Rheumatic Diseases. no.81 London: Bmj Publishing Group, pp. 774-775.
P. Robinson, et al., “LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS”, Annals of the Rheumatic Diseases, vol. 81, London: Bmj Publishing Group, 2022, pp.774-775.
Robinson, P., Maksymowych, W.P., Gensler, L.S., Rudwaleit, M., Hoepken, B., Bauer, L., Kumke, T., Kim, M., Deodhar, A.: LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS. Annals of the Rheumatic Diseases. 81, p. 774-775. Bmj Publishing Group, London (2022).
Robinson, P., Maksymowych, W. P., Gensler, L. S., Rudwaleit, Martin, Hoepken, B., Bauer, L., Kumke, T., Kim, M., and Deodhar, A. “LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS”. Annals of the Rheumatic Diseases. London: Bmj Publishing Group, 2022.Vol. 81. 774-775.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar